Raymond James analyst Justin Jenkins raised the firm’s price target on Delek US (DK) to $37 from $33 and keeps an Outperform rating on the shares. Raymond James expects Q3 to be “solid” for nearly all refiners, and strong overall crack spreads should push refining earnings to levels not seen since early-2024, the analyst tells investors in a research note. The firm adds that Q4 is off to a solid start, though the typical rollover in seasonal margins is starting to emerge, and believes 4Q25/2026 revisions need to stay positive for refiners to continue to work.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DK:
- Delek US initiated with an Overweight at Wells Fargo
- Delek US price target raised to $35 from $19 at JPMorgan
- Delek US Holdings: Hold Rating Maintained Amid Modest EBITDA Growth and Stable Margins
- Delek US price target raised to $33 from $20 at Scotiabank
- Delek US upgraded to Equal Weight from Underweight at Morgan Stanley